title: Testicular lymphoma.
authors.affiliation: Hematology & Oncology Associates of NE PA, PC, The Commonwealth Medical College Scranton, PA, USA.
authors.forename: Lisa C
authors.initials: LC
authors.lastname: Thomas
authors.forename: Christian
authors.initials: C
authors.lastname: Adonizio
authors.forename: Joanne
authors.initials: J
authors.lastname: Filicko-O'Hara
authors.forename: Ali R
authors.initials: AR
authors.lastname: Golshayan
authors.forename: Luciano J
authors.initials: LJ
authors.lastname: Costa
authors.forename: Gloria J
authors.initials: GJ
authors.lastname: Morris
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000473:pathology / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D009919:Orchiectomy; D011241:Prednisone / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant; D000069283:Rituximab; D013736:Testicular Neoplasms / Q000473:pathology / Q000628:therapy*; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone